Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-19 4:48 pm Unchanged | 2023-09-19 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 8,901,750 30.100% | 0 (Unchanged) | Filing History |
| 2023-04-04 06:00 am Sale | 2023-04-03 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 8,901,750 30.300% | -550,323 (-5.82%) | Filing History |
| 2023-02-14 4:36 pm Purchase | 2022-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 9,452,073 32.700% | 134,022 (+1.44%) | Filing History |
| 2022-02-14 4:57 pm Sale | 2021-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 9,318,051 32.400% | -316,950 (-3.29%) | Filing History |
| 2021-02-16 5:14 pm Purchase | 2020-12-31 | 13G | BioXcel Therapeutics, Inc. BTAI | BioXcel Holdings Inc. | 9,635,001 38.590% | 9,635,001 (New Position) | Filing History |